All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CNS PHARMACEUTICALS, INC. Last Reported: 2/29/2024 Stock Symbol: CNSP

Business Address

2100 WEST LOOP SOUTH
SUITE 900
HOUSTON , TX US 77027

Mailing Address

2100 WEST LOOP SOUTH
SUITE 900
HOUSTON , TX US 77027
Phone Number: 1-800-946-9185 / State Incorporated: NV / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Cash and Cash Equivalents $909,547.00 $4,279,251.00 $10,055,407.00 $7,027,470.00 $8,958,880.00 $12,440,498.00 $8,326,223.00 $6,885,572.00 $11,075,200.00 $14,039,493.00 $1,307,098.00 $2,625,771.00 $5,379,790.00 $7,241,288.00 $630,109.00 $911,928.00 $155,021.00 $282,736.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $1,152,298.00 $1,791,775.00 $2,509,238.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $2,061,845.00 $6,071,026.00 $12,564,645.00 $8,700,369.00 $11,397,410.00 $14,733,170.00 $11,155,830.00 $13,883,487.00 $12,786,366.00 $15,495,843.00 $2,516,177.00 $3,954,491.00 $6,188,536.00 $7,893,910.00 $1,390,363.00 -- -- $588,133.00 -- -- -- --
Property Plant and Equipement $3,470.00 $3,382.00 $5,664.00 $8,522.00 $10,970.00 $12,734.00 $17,526.00 $20,895.00 $24,105.00 $23,431.00 $28,158.00 $31,321.00 $22,658.00 $18,165.00 $7,512.00 -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $2,328,046.00 $6,451,604.00 $13,053,115.00 $9,637,927.00 $12,447,312.00 $15,871,867.00 $11,507,494.00 $14,238,520.00 $13,144,609.00 $15,853,412.00 $2,985,237.00 $3,985,812.00 $6,211,194.00 $7,912,075.00 $1,397,875.00 -- -- $683,333.00 -- -- -- --
Accounts Payable -- $3,570,638.00 $3,681,900.00 $1,005,043.00 $490,886.00 $489,716.00 $1,461,574.00 $892,492.00 $1,057,684.00 $946,330.00 $250,181.00 $150,513.00 $141,247.00 $243,666.00 $278,341.00 -- -- $128,071.00 -- -- -- --
Accrued Liabilities -- $260,137.00 $828,391.00 $200,000.00 $276,573.00 $307,012.00 $901,222.00 $760,678.00 $534,940.00 $519,804.00 $260,601.00 $110,692.00 $144,793.00 $21,500.00 $46,069.00 -- -- $23,599.00 -- -- -- --
Total Current Liabilities $4,068,798.00 $3,997,171.00 $4,920,259.00 $1,244,303.00 $923,856.00 $1,069,300.00 $2,407,428.00 $1,830,753.00 $1,901,757.00 $1,905,428.00 $510,782.00 $261,205.00 $336,040.00 $310,999.00 $1,397,659.00 -- -- $1,232,631.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-64,191,653.00 $-59,668,858.00 $-50,715,677.00 $-44,752,765.00 $-41,333,212.00 $-37,767,260.00 $-32,187,768.00 $-28,373,420.00 $-24,559,747.00 $-20,946,343.00 $-17,941,438.00 $-15,930,374.00 $-13,456,603.00 $-11,488,472.00 $-8,961,124.00 -- -- $-7,611,261.00 -- -- -- --
Total Stockholders' Equity $-1,740,752.00 $2,454,433.00 $8,132,856.00 $8,393,624.00 $11,523,456.00 $14,802,567.00 $9,100,066.00 $12,407,767.00 $11,242,852.00 $13,947,984.00 $2,474,455.00 $3,724,607.00 $5,875,154.00 $7,601,076.00 $216.00 $377,704.00 $-716,783.00 $-549,298.00 $-347,031.00 $-197,843.00 $34,967.00 $-58,532.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $2,328,046.00 $6,451,604.00 $13,053,115.00 $9,637,927.00 $12,447,312.00 $15,871,867.00 $11,507,494.00 $14,238,520.00 $13,144,609.00 $15,853,412.00 $2,985,237.00 $3,985,812.00 $6,211,194.00 $7,912,075.00 $1,397,875.00 -- -- $683,333.00 -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $3,410,572.00 $6,413,312.00 $9,300,055.00 $2,207,913.00 $3,742,703.00 $1,521,364.00 $7,449,869.00 $4,871,853.00 $2,206,874.00 $5,061,734.00 $3,147,636.00 $1,492,285.00 $613,077.00 $1,854,334.00 $369,940.00 $42,730.00 $48,307.00 $21,267.00 $21,267.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $4,533,840.00 $4,025,386.00 $15,267,107.00 $9,765,129.00 $3,564,341.00 $2,781,773.00 $11,234,378.00 $7,420,977.00 $3,609,657.00 $9,454,607.00 $6,452,966.00 $2,473,771.00 $1,968,131.00 $3,832,977.00 $1,309,246.00 $415,062.00 $195,090.00 $881,787.00 $673,204.00 -- -- --
Loss from Operations $-4,533,840.00 $-8,951,897.00 $-15,267,107.00 $-3,419,015.00 $-3,564,341.00 $-2,781,773.00 $-11,234,378.00 $-7,420,977.00 $-3,609,657.00 $-9,454,607.00 $-6,452,966.00 $-2,473,771.00 $-1,968,131.00 $-3,832,977.00 $-1,309,246.00 $-415,062.00 $-195,090.00 $-881,787.00 $-673,204.00 -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-4.05 $-3.10 $-11.22 $-0.25 $-0.16 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 3,327,636 2,893,682 1,361,737 40,032,481 39,427,218 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-1.08 $-3.10 $-11.22 $-0.25 $-0.16 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 3,327,636 2,893,682 1,361,737 39,631,939 39,427,218 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 75,000,000 75,000,000 75,000,000 75,000,000 -- 75,000,000 75,000,000 75,000,000 75,000,000 75,000,000 75,000,000 75,000,000 -- 75,000,000 75,000,000 -- -- 75,000,000 -- -- -- --
Common Stock Shares Outstanding 4,207,068 4,140,960 1,617,325 40,032,481 40,032,481 40,032,481 27,460,735 27,379,485 25,352,809 23,856,151 16,652,225 16,450,234 -- 16,450,234 13,587,004 -- -- 12,694,504 -- -- -- --
Common Stock Value $4,207.00 $4,141.00 $1,617.00 $40,032.00 $40,032.00 $40,032.00 $27,460.00 $27,379.00 $25,352.00 $23,856.00 $16,652.00 $16,450.00 $16,450.00 $16,450.00 $13,587.00 -- -- $12,695.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 -- 5,000,000 5,000,000 -- -- 5,000,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 $0.00 -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com